The Burden of Vaccine-Preventable Diseases in Adults by Lam, Jerika & Goad, Jeff
Chapman University 
Chapman University Digital Commons 
Pharmacy Faculty Articles and Research School of Pharmacy 
3-31-2017 
The Burden of Vaccine-Preventable Diseases in Adults 
Jerika Lam 
Chapman University, jlam@chapman.edu 
Jeff Goad 
Chapman University, goad@chapman.edu 
Follow this and additional works at: https://digitalcommons.chapman.edu/pharmacy_articles 
 Part of the Diseases Commons, and the Public Health Commons 
Recommended Citation 
Lam J, Goad J. The burden of vaccine-preventable diseases in adults. Pharmacy Times. 
https://www.pharmacytimes.com/publications/supplementals/2017/
immunizationsupplementmarch2017/the-burden-of-vaccinepreventable-diseases-in-adults. Published 
March 31, 2017. 
This Article is brought to you for free and open access by the School of Pharmacy at Chapman University Digital 
Commons. It has been accepted for inclusion in Pharmacy Faculty Articles and Research by an authorized 
administrator of Chapman University Digital Commons. For more information, please contact 
laughtin@chapman.edu. 
The Burden of Vaccine-Preventable Diseases in Adults 
Comments 
This article was originally published in Pharmacy Times in 2017. 
Copyright 
Pharmacy Times 
This article is available at Chapman University Digital Commons: https://digitalcommons.chapman.edu/
pharmacy_articles/457 
The Burden of Vaccine-Preventable Diseases in Adults 
2017-03-31 13:57:37 
Jerika Lam, PharmD, and Jeff Goad, PharmD, MPH 
 
Among the many treatments for diseases, vaccines are the safest and most cost-effective form of 
preventive medicine in the United States. Despite a rise in vaccination rates among young adults 
between 1993 and 2013, a persistently low uptake of routinely recommended immunizations 
remains among adults 50 years or older.1-3 Except for modest increases in tetanus, diphtheria, 
and pertussis vaccination for adults 19 years or older and herpes zoster (shingles) vaccination 
among those 60 years or older, adult vaccination coverage did not improve from 2013 to 2014. 
The CDC reports that a low trend for influenza, human papilloma virus (HPV), pneumococcal, 
hepatitis B (for health care providers), and herpes zoster vaccinations continues to persist among 
adults.4 These poor vaccination rates could be attributed to gaps in insurance coverage, personal 
beliefs, and disparities in access to vaccines. As a result, the burden of vaccine-preventable 
diseases translates into significant social, public health, and economic costs within our society. 
 
At present, 8 vaccines have age-only recommendations by the CDC to protect adults against 11 
diseases (Table 15). An additional 5 vaccines can be used to protect adults with specific medical 
conditions or activities. The CDC delineates 5 age groups for adult vaccination: 19 to 21 years, 
22 to 26 years, 27 to 59 years, 60 to 64 years, and ≥65 years. Also available from the CDC is an 
immunization table that lists medical conditions and activities that serve as indications or 
contraindications to adult vaccines.5 Because of more effective childhood immunization 
programs, diseases such as measles, rubella, diphtheria, tetanus, and pertussis are rare among 
adults 19 years or older.6 However, reports of limited adult cases of measles, mumps, or pertussis 




In 2015, there were 14.1 million cases of vaccine- preventable diseases attributable to 
unvaccinated adults. Of the total economic burden of approximately $9 billion due to direct costs 
and productivity losses from vaccine-preventable diseases, lack of vaccination was responsible 
for $7.1 billion.8 Table 29 displays the burden of some common vaccine-preventable diseases 
from 2012 to 2016.9 It is clear that case rates have declined more than 90% for all major diseases 
since their peak years. However, there have been some disturbing trends with measles and 




MEASLES, MUMPS, AND RUBELLA 
Measles and mumps are viral infections that are highly contagious via the respiratory route. 
Although the vaccine for both of these diseases is contained in the measles, mumps, and rubella 
(MMR) vaccine and childhood immunization rates are high, outbreaks continue. In the United 
States, measles cases start as imported disease, mostly from travelers to nations with low 
vaccination rates. Thus, it is essential that individuals in the United States who travel to other 
countries receive 2 doses of MMR before departing. Mumps has also experienced a resurgence 
in both travelers to Europe and college campuses in the United States. In many of these settings, 
2-dose MMR vaccination is high, but even the small failure rate associated with the vaccine can 
allow outbreaks to occur.10 
 
INFLUENZA 
According to the CDC, fewer than 50% of adults chose to receive the flu vaccine in the 2015-
2016 season. More effort is required to ensure that individuals who see their health care 
providers during the flu season receive the vaccination. In addition, health care providers are 
strongly advised to receive annual influenza vaccinations.11 Over several years, pharmacists have 
continued to lead other medical professions in getting their flu shot.12 If not vaccinated, they may 
serve as a source of influenza virus transmission to vulnerable patients. 
 
HERPES ZOSTER  
Herpes zoster has been increasing since 1992, and 1 out every 3 individuals in the United States 
will develop it during their lifetime. However, only 28% get vaccinated.13 Reasons for the low 
herpes zoster vaccination rates include in some cases the high cost of the vaccine, challenges to 
stocking the vaccine (requires freezer storage), billing issues, and out-of-pocket costs.4 Because a 
great proportion of all herpes zoster vaccine is distributed to pharmacies, and pharmacists in all 
50 states can administer the vaccine, it is imperative that pharmacists take a proactive role in 
zoster vaccination. 
 
OVERCOMING BARRIERS TO VACCINATION 
For the unvaccinated adult group 65 years or older, the incidence of influenza and pneumococcal 
disease accounts for the greatest burden of disease,14,15 as both influenza and pneumococcal 
disease can result in hospitalization and death. However, unvaccinated individuals in younger 
age groups account for a higher percentage of cases of vaccine-preventable diseases: 85% of 
adults aged 19 to 49 years, 81% of adults aged 50 to 64 years, and 56% of adults 65 years or 
older.8 
 
Patient barriers to vaccination include lack of awareness of the need for the vaccine, disbelief 
that receiving the vaccine will be helpful, low education level, busy schedules and competing 
demands, and lack of recommendations by a health care provider.16-19 The last barrier centers on 
provider issues: research shows that some physicians do not believe vaccines are effective; 
therefore, they do not recommend vaccination to their patients, do not stock the vaccines, and fail 
to act as proponents for adult vaccination.20-22 
 
Recently, the CDC and the National Vaccine Advisory Committee proposed 4 essential 
components for improving vaccination rates: (1) assess immunization status, (2) recommend 
(make strong recommendations for needed vaccines), (3) administer or refer (stock and 
administer needed vaccines or refer to a provider who can), and (4) document (using 
immunization information systems or immunization registries).23 Research has shown that 
individuals who are steadfast on refusing vaccination are still open to listening and even getting 
vaccinated when a health care provider makes a strong recommendation.24 
 
Now that pharmacists have expanded authority to vaccinate in every state, they need to become 
proactive vaccinators by identifying and making strong recommendations for all patients. Doing 
so will help reduce the burden of influenza, HPV, pneumococcal disease, herpes zoster, and 
other vaccine-preventable diseases. 
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